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Objective- To compare the effects of 3 contrast medium injection protocols on attenuation 
values of the adrenal glands in dogs. 
Animals- 9 healthy Beagles.  
Procedures- Multislice CT scans were carried out before and at 19 time points after contrast 
medium injection. Following protocols were evaluated in a randomized cross-over trial: 700 
mg iodine/kg at constant injection rate over 20 s (full constant (FC)), 700 mg iodine/kg 
following an exponential decay curve over 20 s (full exponential (FE)) and 350 mg iodine/kg 
at constant injection rate over 10 s (half constant (HC)).  
Results- Peak attenuation (median) was 129 Hounsfield units (HU), 133 HU and 87 HU for 
injecting at FC, FE and HC rates, respectively. Peak attenuation differed significantly 
between FC and HC injections and between FE and HC injections. Time to peak attenuation 
(median) did not differ significantly between injection methods and was 30 s, 23 s and 15 s in 
FC, FE and HC injections, respectively. 
Conclusions and Clinical Relevance- Dose of contrast medium and timing of scanning, but 
not injection technique, affect peak attenuation values in adrenal glands. The exponential 
injection method was complex and seemed prone to error. A constant injection protocol using 
700 mg iodine/kg and scanning approximately 30 s after contrast injection provides images 
with maximum adrenal attenuation values in healthy dogs. 
 






Ziel- Die Pharmakokinetik von 3 verschiedenen Kontrastmittel-Injektionsprotokollen bei 
Nebennieren von Hunden zu untersuchen.  
Tiere- 9 gesunde Beagles. 
Studienaufbau- Computertomographie(CT)-Bilder wurden vor und an neunzehn Zeitpunkten 
nach Kontrastmittelinjektion aufgenommen. In der randomisierten cross-over Studie wurden 
folgende Protokolle evaluiert: 700 mg Iod/kg über 20 Sek in konstanter Injektionsrate (ganze 
Dosis konstant (GK)) und in exponentieller Injektionsrate (ganze Dosis exponentiell (GE)) 
sowie 350 mg Iod/kg über 10 Sek in konstanter Injektionsrate (halbe Dosis konstant (HK)).  
Resultate- Die maximale Attenuierung (Median) bei GK betrug 129 HU und wurde nach 30 
Sek (Median) erreicht. Für GE betrugen die Werte 133 HU nach 23 Sek und für HK 87 HU 
nach 15 Sek. Die Werte der maximalen Attenuierung der GK und der GE unterschieden sich 
signifikant von der HK. Die Zeit bis zur maximalen Attenuierung unterschied sich nicht 
signifikant zwischen den Protokollen. 
Schlussfolgerung und klinische Relevanz- Die Dosis des Kontrastmittels sowie der 
Messzeitpunkt, jedoch nicht die Injektionstechnik, beeinflussen die maximale Attenuierung 
der Nebennieren. Die exponentielle Injektionsrate ist komplex und fehleranfällig. Bei 
konstanter Injektionsrate von 700 mg Iod/kg und Aufnahmen nach 30 Sek ist die maximale 
Attenuierung der Nebennieren bei gesunden Hunden garantiert. 
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Contrast-enhanced CT has been used with in-creasing frequency in veterinary medicine to 
evaluate various organs and disease processes. The 
pharmacokinetics of the contrast medium deter-
mines the optimal time period for image generation 
because image acquisition should coincide with the 
time of highest contrast concentration in the target 
area and the time of maximum difference in attenu-
ation values between healthy and diseased tissue. 
When iodinated contrast medium is used, numerous 
pharmacokinetic and physiological interactions af-
fect contrast attenuation.1–3 Patient- and injection- 
related factors are the 2 most important determi-
nants of contrast attenuation. Patient-related factors 
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OBJECTIVE
To assess the effects of 3 contrast medium injection techniques on attenua-




3 protocols were evaluated in a randomized cross-over design study: 700 mg 
of iodine/kg at a constant injection rate over 20 seconds (full-dose constant 
rate), the same dose at a rate following an exponential decay curve over 20 
seconds (full-dose decelerated rate), and 350 mg of iodine/kg at a constant 
injection rate over 10 seconds (half-dose constant rate). Multislice CT images 
were obtained before and at predetermined time points after the start of 
contrast medium injection.
RESULTS
Median peak attenuation values were 129, 133, and 87 Hounsfield units with 
the full-dose constant rate, full-dose decelerated rate, and half-dose constant 
rate injection protocols, respectively. Peak attenuation differed significantly 
between the full-dose constant rate and half-dose constant rate injection 
protocols and between the full-dose decelerated rate and half-dose constant 
rate injection protocols. Median time to peak attenuation did not differ sig-
nificantly among injection methods and was 30, 23, and 15 seconds for the 
full-dose constant rate, full-dose decelerated rate, and half-dose constant rate 
injections, respectively.
CONCLUSIONS AND CLINICAL RELEVANCE
The dose of contrast medium and the timing of postinjection CT scanning 
were main determinants of peak attenuation for adrenal glands in healthy 
dogs; effects of the 3 injection protocols on attenuation were minor. The ex-
ponentially decelerated injection method was subjectively complex. A con-
stant injection protocol delivering 700 mg of iodine/kg over 20 seconds, with 
scans obtained approximately 30 seconds after starting contrast medium in-
jection, provided images with maximum adrenal gland attenuation values. (Am 
J Vet Res 2016;77:144–150)
include cardiovascular status, body weight, hydra-
tion status, and renal function. Variables related to 
contrast medium injection are of equal importance 
and include volume, concentration, and rate of injec-
tion. In addition, the injection protocol (ie, whether 
the contrast agent is infused in monophasic or multi- 
phasic fashion or with subsequent saline flushes) af-
fects vascular and parenchymal attenuation.1–4
The CT appearance of adrenal glands has been de-
scribed in healthy dogs, in dogs with pituitary-depen-
dent hyperadrenocorticism, and in dogs with primary 
adrenal neoplasia.5–10 A recent study11 compared the 
CT findings of 17 dogs with different types of adre-
nal tumors.11 Vascular invasion was reliably identified, 
but distinction among tumor types was not possible 
on the basis of CT findings alone. However, other in-
vestigators had observed that contrast attenuation 
ABBREVIATION
HU  Hounsfield units
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of pheochromocytomas was significantly increased, 
compared with that of adenocarcinomas.a,b
To our knowledge, there have been no CT studies 
on the effect of injection-related factors on contrast 
attenuation of canine adrenal glands. Thus, the pur-
pose of the study reported here was to investigate and 
compare the effects of 3 different contrast medium 
injection protocols on contrast attenuation of adre-
nal glands in healthy dogs. The 3 protocols selected 
included constant injection of contrast medium, ex-
ponentially decelerated injection of the same dose, 
and constant-rate injection of half the dose over half 
the time. We hypothesized that there would be a dif-
ference in peak attenuation and time to peak attenu-
ation among the 3 protocols and, more importantly, 
that these differences would be identified between 
the full-dose constant rate injection and the full-dose 
decelerated rate injection. Injecting half the dose over 
half the time was done to examine whether injecting a 
lower dose over a shorter period of time would result 
in the same degree of attenuation as injecting a higher 
dose over a longer period of time. The ultimate goal 
was to establish a standardized protocol for CT scan-
ning of normal adrenal glands with optimum attenua-
tion in healthy dogs.
Materials and Methods
Dogs
Nine healthy sexually intact (4 males and 5 fe-
males) Beagles were used in the study.  The dogs were 
28 to 33 months old (median, 33 months; mean, 31 
months) and weighed 9.5 to 14.8 kg (median, 14 kg). 
All dogs were considered healthy on the basis of re-
sults of physical examination, CBC, serum biochemi-
cal analysis, and urinalysis.  The dogs were housed at a 
university facility in standard kennels in groups of 2 to 
4, fed dry adult maintenance dog food, and had access 
to water ad libitum. All procedures were approved by 
the Cantonal Veterinary Office of Zurich (permission 
No.  TVB 186/2012) and conducted in accordance 
with guidelines established by the Animal Welfare Act 
of Switzerland.
Procedures
A randomized crossover study design was used. 
Each dog was assigned an identification number by 
an investigator drawing its name from a bag and then 
drawing a number (1 to 9) from another bag. The or-
der of the injection protocols for each dog was deter-
mined by drawing the sequence from a third bag. Each 
dog underwent each of the 3 IV contrast medium in-
jection protocols: the full dose (700 mg of iodine/kg) 
delivered at a constant rate over 20 seconds (full-dose 
constant rate), the same dose delivered by an expo-
nentially decelerated injection method over 20 sec-
onds (full-dose decelerated rate), and one-half of the 
full dose (350 mg of iodine/kg) delivered at a constant 
rate over 10 seconds (half-dose constant rate). For the 
exponential decay curve (y = a•e–t/τ + b),12,13 where y 
is the injection rate, a is the initial injection rate – b, e 
is a numerical constant equal to 2.71828 (Euler num-
ber), t is time after the start of injection, τ is tan (ex-
ponential time constant), and b is the approximated 
final injection rate, the parameters were set at a = 5, 
b = 0.63, and τ = 4 (these values were chosen em-
pirically to result in an injection curve with a reason-
able decay over the injection time). The half-life λ was 
calculated as 1/τ.  The area under the injection curve 
represented the dose of contrast medium expressed 
as F(t) = ∫ a • e–t/τ + b dt, where F(t) is the amount 
of contrast medium injected at the time point t, t is 
time after the start of injection, and dt represents the 
differential of the function. For a given injection time 
t1, this formula becomes F(t1) = a τ (1 – e–t1/τ) + bt1 
and is thus used to calculate the applicable dose. The 
injection was divided into 6 steps: 3 steps covered τ, 
and the other 3 steps were distributed equally over 
the remaining injection time (Figure 1). Each dog re-
ceived the 3 different injection protocols 7 days apart. 
The washout period was determined on the basis of 
study results regarding pharmacokinetics and biodis-
tribution of iodinated contrast agents in humans and 
healthy dogs.14,15
All dogs received acepromazine maleatec (0.03 
mg/kg, IM) and methadone hydrochlorided (0.5 mg/
kg, IM) as premedication.  After approximately 20 
to 30 minutes, the hair was clipped from the dorsal 
aspect of a forelimb, an IV catheter was aseptically 
placed in the cephalic vein, and propofole (4 mg/kg, 
IV) was injected to allow endotracheal intubation. The
Figure 1—Schematic illustration of the exponential decay 
curve injection method described by the mathematical equa-
tion y = a•e–t/τ + b, where y is injection rate, a is the initial 
injection rate – b, e is a numerical constant equal to 2.71828 
(Euler number), t is time after the start of injection, τ is tan (ex-
ponential time constant), and b is the approximated final injec-
tion rate.  The half-life λ is calculated as 1/τ.  The area under the 
curve represents the contrast medium dose expressed as F(t) = 
∫ a•e –t/τ + b dt, where F(t) is the amount of contrast medium 
injected at the time point t, t is time after start of injection, 
and dt represents the differential of the function. For a given 
injection time t1, this formula becomes F(t1) = a τ (1 – e–t1/τ) + 
bt1 and thus calculates the applicable dose. The injection was 
divided into 6 steps: 3 steps covered τ and the other 3 steps 
were distributed equally over the remaining injection time.
4
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dogs were then connected to a semiclosed circle sys-
tem and mechanically ventilated throughout the study 
period. Anesthesia was maintained with sevofluranef 
in oxygen. A multiparameter monitor was used to re-
cord heart rate, respiratory rate, body temperature, 
peripheral oxygen saturation, arterial blood pressure 
(noninvasive method), inspiratory and expiratory oxy-
gen concentrations, end-tidal CO2 concentration, and 
sevoflurane concentration. The dogs were positioned 
in dorsal recumbency for the CT scans, and transient 
apnea was induced for every scan by administration 
of a rocuronium bromideg bolus (0.3 mg/kg, IV) and 
momentary suspension of mechanical ventilation 
(duration, ≤ 120 seconds). All serial CT scans were 
conducted in a cranial-to-caudal direction from the 
midliver level to the level of the caudal pole of the 
left kidney. After an unenhanced scan, iodinated low-
osmolar contrast mediumh with a concentration of 
350 mg of iodine/mL (warmed to room temperature 
[21°C]) was administered as described via an automat-
ic programmable injectori through the cephalic ve-
nous catheter. Subsequent CT scans were carried out 
at the following time points (minutes:seconds) after 
the start of injection: 0:00, 0:15, 0:30, 0:45, 1:00, 1:15, 
1:30, 2:30, 3:30, 4:30, 5:30, 6:30, 7:30, 8:30, 9:30, 10:30, 
12:30, 14:30, and 16:30. Dogs were kept anesthetized 
until 10 minutes after contrast medium injection pro-
cedures. During that time, blood pressure and heart 
rate were monitored. Thereafter, dogs recovered and 
were routinely monitored (with temperature, heart 
rate, and respiratory rate assessed every 5 minutes) for 
another 30 minutes.  Then dogs were moved to a ward 
under routine observation for another 12 hours until 
they were returned to their normal environment. Car-
diovascular data (heart rate and blood pressure) and 
data related to adverse effects (not requiring interven-
tion) during the study period were recorded for use in 
another concurrently performed study.
To ensure that peak enhancement was not missed 
with the described CT protocol, 4 of the 9 dogs under-
went an additional CT scan with a full-dose constant 
rate injection protocol but with the imaging proce-
dure revised according to the following procedure: 
the left adrenal gland was scanned at a single loca-
tion (1 plane) every 2 seconds for 2 minutes after the 
start of contrast medium injection. This additional CT 
procedure was conducted ≥ 7 days after the previous 
scan.
A 16-slice CT scanning machinej was used with 
the following settings: voltage peak, 120 kVp; cur-
rent, 250 mA; pitch, 0.688; rotation time, 0.75 sec-
onds; and detector collimation, 16 X 0.75 mm. The 
raw data were reconstructed in a soft tissue algo-
rithm with an increment of 0.5 mm and a matrix of 
512 X 512 pixels. The images were exported to a 
workstationk and reviewed with a window width of 
600 and window level of 150 by one of the authors 
(AB) who was not blinded to treatment group and 
who worked under regular (daily) supervision of a 
board-certified radiologist (MD).
Measurement techniques
To quantify attenuation, a slice was selected in 
which both adrenal glands were visible but the phrenico- 
abdominal artery and vein were not. The contour of 
each adrenal gland was outlined with the closed poly-
gon tool in the workstation software, excluding the 
margins, periadrenal fat, and blood vessels. The soft-
ware calculated the mean and SD attenuation of the 
tissue within the region of interest.
Pharmacokinetic parameters were analyzed with 
the aid of time-attenuation curves generated by use of 
the workstation software. Peak attenuation and time 
to peak attenuation were used to evaluate distribution 
of the contrast medium in the adrenal glands. Fifteen 
to 17 measurement points were available for analysis 
of the washout of the contrast medium. The slopes of 
the curve for early (α) and late (β) washout phases 
were calculated with the following pharmacokinetic 
equation: c(t) = A e–α•t + B e–β•t, where c(t) is opacity 
(measured in HU) as a function of time; A and B are 
derived from the rate constants, the volume of distri-
bution, and the dose administered; α and β are func-
tions of the pharmacokinetic rate constants describ-
ing distribution and excretion of the contrast medium, 
respectively; and t is the time after start of injection15 
(Figure 2).
Statistical analysis
To determine the number of dogs required for an 
acceptable probability of finding an effect of the injec-
tion method, a power analysis (α = 0.05; β = 0.9) was 
conducted after the investigation of the first 6 dogs by 
means of a freely available software program.l At least 
6 dogs were required to provide a statistical power 
of 90%, and it was determined that 9 dogs should be 
included in the study to ensure that ≥ 6 complete data 
sets were available for statistical analysis. Commercial 
softwarem,n was used to perform nonparametric tests 
for statistical analysis, and results were expressed as 
Figure 2—Graphic image depicting washout of iodinated con-
trast medium in a healthy Beagle following administration of the 
agent with a full-dose constant rate injection protocol. Closed 
circles represent the measured values, and open circles repre-
sent the estimated values.
5
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median and range. The Wilcoxon rank sum test was 
used to analyze differences in attenuation values be-
tween the left and right adrenal glands. Differences 
between injection protocols were tested by the Fried-
man test and the Dunn posttest. Differences were con-
sidered significant at P < 0.05.
Results
All dogs were recovered following anesthesia. No 
serious immediate or delayed reactions to the contrast 
medium administration (ie, response requiring an in-
tervention) occurred during the study.
Peak attenuation and time to peak  
attenuation
Attenuation values did not differ between the left 
and right adrenal glands in the unenhanced scan (P 
= 0.15) or in scans performed with the full-dose con-
stant rate injection (P = 0.82), with the full-dose decel-
erated rate injection (P = 1.0), or with the half-dose 
constant rate injection (P = 0.57). The values for the 
left and right adrenal glands were therefore combined 
for further analysis.
For the full-dose constant rate injection, peak at-
tenuation for combined (left and right) adrenal glands 
was 129 HU (range, 90.1 to 152.3 HU) and time to 
peak attenuation was 30 seconds (range, 15 to 45 sec-
onds); for the full-dose decelerated rate injection, the 
values were 132.5 HU (range, 99.4 to 172 HU) and 
23 seconds (range, 15 to 30 seconds), respectively; 
and for the half-dose constant rate injection, the val-
ues were 86.95 HU (range, 55.3 to 103.9 HU) and 15 
seconds (range, 15 to 30 seconds), respectively. Peak 
attenuation for unenhanced CT scans was 18.1 HU 
(range, 11.7 to 22.7 HU). Peak attenuation differed sig-
nificantly between unenhanced CT scans and scans 
performed with the full-dose constant rate, full-dose 
decelerated rate, and half-dose constant rate injection 
protocols (P < 0.001, < 0.001 and < 0.05, respectively; 
Figure 3). This variable also differed significantly be-
tween the full-dose constant rate and half-dose con-
stant rate (P < 0.001) and between the full-dose decel-
erated rate and half-dose constant rate (P < 0.001), but 
not between the full-dose constant rate and full-dose 
decelerated rate injection protocols. There was no sig-
nificant (Friedmann test, P < 0.03; Dunn multiple com-
parisons test, P > 0.05) difference in time to peak at-
tenuation among the full-dose constant rate, full-dose 
decelerated rate, and half-dose constant rate protocols.
For the additional CT scan of left adrenal glands 
performed with full-dose constant rate injection and 
the revised imaging protocol (every 2 seconds for 2 
minutes; n = 4 dogs), peak attenuation was 160.15 HU 
(range, 97.9 to 175.6 HU; Figure 4). The time to peak 
attenuation in this experiment was 35 seconds (range, 
28 to 40 seconds).
Time-attenuation curves during  
washout
The slopes of the curve for early (α) and late (β) 
washout phases of contrast medium following use of 
the full-dose constant rate, full-dose decelerated rate, 
and half-dose constant rate injection protocols were 
summarized (Table 1). The slopes of the early and 
late washout phases did not differ among injection 
protocols.
Discussion
Injection-related variables including iodine con-
centration, injection rate, duration of injection, and in-
jection protocol are important factors that affect the 
timing and degree of attenuation in contrast-enhanced 
CT examinations.1–4 In the present study, we assessed 
attenuation of adrenal glands in healthy dogs with and 
without contrast medium administration by 1 of 3 
protocols: full-dose constant rate injection (700 mg of 
iodine/kg, IV, delivered at a constant rate over 20 sec-
onds), full-dose decelerated rate injection (700 mg of 
Figure 3—Scatterplot showing peak attenuation of adrenal 
glands (mean of left and right for each of 9 dogs) measured in 
unenhanced CT scans and scans performed with full-dose con-
stant rate (FDCR; 700 mg of iodine/kg, IV, at a constant injec-
tion rate over 20 seconds), full-dose decelerated rate (FDDR; 
700 mg of iodine/kg, IV, following an exponential decay curve 
over 20 seconds), and half-dose constant rate (HDCR; 350 mg 
of iodine/kg, IV, at a constant rate over 10 seconds) contrast 
medium injection protocols.  The horizontal lines depict the 
median of 9 measurements.
Figure 4—Median and range attenuation of left adrenal glands 
in 4 dogs over time after injection of contrast medium with the 
full-dose constant rate injection protocol. For this experiment, 
the imaging protocol was revised to scan 1 adrenal gland/dog 
in a single plane every 2 seconds over a 2-minute period. Times 
were measured from the start of contrast medium injection.
6
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iodine/kg, IV, at a rate following an exponential decay 
curve over 20 seconds), and half-dose constant rate in-
jection (350 mg of iodine/kg, IV, at a constant rate over 
10 seconds). Peak attenuation was significantly associ-
ated with the dose of contrast medium used. Of note, 
the time to peak enhancement was not significantly 
affected by the injection protocol. It is known that the 
contrast medium dose or volume affects peak attenu-
ation; the degree of contrast attenuation increases at a 
rate proportional to the amount of iodine deposited 
in a target organ or intravascular blood volume.1–3,16 
Because injection duration (volume divided by injec-
tion rate) also affects attenuation values, we investi-
gated whether injecting a lower dose in a shorter time 
had the same effect as injecting a higher dose over 
a longer time. Interestingly, peak attenuation was sig-
nificantly decreased when the lower contrast medium 
dose was used, even though it was administered in 
half the time. This was most likely attributable to the 
fact that the injection rates of both protocols were the 
same (2 mL/kg/20 s for the full-dose constant rate in-
jection vs 1 mL/kg/10 s for the half-dose constant rate 
injection). Shortening the injection duration without 
increasing the injection rate results in the administra-
tion of a smaller contrast medium volume and thus 
a proportional decrease in the magnitude of vascular 
and parenchymal attenuation.1
Time to peak attenuation is another factor that 
was shown to be affected by the duration of contrast 
medium injection in CT examination of the pulmonary 
arteries, aorta, and liver of humans1,2 and dogs.17,18 
Short injection duration resulted in a short time to 
peak attenuation and prolonged injection duration in 
a later time to peak attenuation of the contrast me-
dium.1,2,17,18 However, to our knowledge, effects of in-
jection protocols on this variable have not previously 
been evaluated for the adrenal glands of any species. 
We expected time to peak attenuation to be shorter 
in dogs following the half-dose constant rate injection 
(duration of 10 seconds) than in the same dogs fol-
lowing the full-dose constant rate injection (duration 
of 20 seconds), but there was no significant difference 
in this variable between the 2 protocols. It is possible 
that the total iodine administration rate, referred to as 
iodine flux and calculated by multiplying the contrast 
injection rate by the iodine concentration, is a more 
crucial determinant of time to peak attenuation than 
the injection duration.2 In the present study, the con-
trast injection rate (2 mL/kg/20 s or 1 mL/kg/10 s) and 
the iodine concentration (350 mg/mL) were the same 
in both injection protocols, which could have dimin-
ished the effect of the injection duration on time to 
peak attenuation.
One goal of this study was to investigate whether 
attenuation values for canine adrenal glands would dif-
fer between constant rate and exponentially deceler-
ated injection methods. The exponential deceleration 
method was complex, required considerable calcula-
tion, and seemed prone to error, but the attenuation 
values for adrenal glands of healthy dogs did not differ 
between the 2 methods. In humans, vascular attenu-
ation values were more uniform when the exponen-
tially decelerated injection method was used for CT 
angiography19; however, parenchymal attenuation was 
not studied. Whether attenuation values would differ 
between these methods in more highly vascularized 
tissue should be evaluated.
The timing and duration of scanning are crucial 
factors in contrast-enhanced CT because of the need 
to coordinate image acquisition with the times when 
contrast attenuation is most informative. Peak attenua-
tion is easily missed if the timing is not optimal. In the 
present study, peak attenuation of the adrenal glands 
in healthy dogs was detected approximately 30 sec-
onds after contrast injection (with median values for 
the 3 contrast injection protocols ranging from 15 to 
30 seconds). However, the ideal interval between in-
jection and CT image acquisition in dogs with adrenal 
gland disease has not been established, and given the 
variable findings of other investigators in regard to the 
usefulness of this modality to distinguish among adre-
nal tumor types,11,a,b further CT studies of dogs with 
adrenal disease are needed to investigate the utility 
of specific attenuation values in this tissue for diag-
nostic purposes. Attenuation on postcontrast images 
has not been shown to allow reliable differentiation of 
benign and malignant adrenal lesions in humans.20–22 
However, adrenal adenomas lose contrast attenuation 
more rapidly than malignant adrenal masses because 
of differences in vascular permeability and density, 
Washout phase
α (s–1) β (s–1)
Full-dose constant rate –0.0157 (–0.0354 to –0.0088) –0.0004 (–0.0008 to –0.00005)
Full-dose decelerated rate –0.0159 (–0.0226 to –0.0101) –0.0004 (–0.0007 to –0.00005)
Half-dose constant rate –0.0187 (–0.0364 to –0.0095) –0.0003 (–0.0007 to –0.0001)
The full-dose constant rate and full-dose decelerated rate injection protocols required IV administration of 
700 mg of iodine/kg (total dose) at a constant injection rate over 20 seconds or at a rate following an exponential 
decay curve over 20 seconds, respectively. The half-dose constant rate injection protocol required IV adminis-
tration of a volume calculated to deliver 350 mg of iodine/kg at a constant rate over 10 seconds.
Table 1—Median (range) slopes of the curve for early (α) and late (β) washout phases of iodinated 
contrast medium administered by means of 1 of 3 protocols to 9 healthy Beagles in a study to assess 
the effects of contrast medium injection technique on attenuation values of canine adrenal glands 
during contrast-enhanced CT.
7
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and the percentage washout of the contrast medium 
on delayed images (at 15 minutes after contrast ad-
ministration) is a reliable indicator for distinguish-
ing between adenomas and malignant masses in hu-
mans.20–22 To our knowledge, washout parameters of 
adrenal masses have not been evaluated in veterinary 
medicine, but our results indicated that under physi-
ologic conditions, the washout of the contrast me-
dium from healthy adrenal glands is exponential and 
independent of dose or injection protocol within the 
tested ranges. This finding was expected, considering 
that, following IV administration, iodinated contrast 
medium is distributed from the vascular to the extra-
vascular space while being continuously excreted by 
the kidneys.2
The viscosity of the nonionic, low-osmolar con-
trast medium used in the present study is affected 
by temperature, and it is lower at higher tempera-
tures.23 Therefore, warming the contrast medium 
reduces viscosity and increases the efficiency of its 
delivery through a catheter, which may influence 
attenuation values.23 We used contrast medium 
warmed to room temperature; whether warming 
the contrast medium to the dogs’ body tempera-
ture would lead to different results is not known. 
Although no adverse effects that required interven-
tion occurred during the study, it should be noted 
that the study population was small, all dogs were 
healthy young adult Beagles.
The relatively small number of dogs (as dictated 
by the Animal Welfare Act of Switzerland) in the study 
limited the power of statistical tests. However, we 
performed a power analysis and determined that the 
minimum number of dogs required for an acceptable 
probability (6 dogs for a statistical power of 90%) of 
finding an effect of the injection method was met.  The 
study had other shortcomings, one being that it was 
an experimental study with results that can be related 
only to healthy dogs without evidence of adrenal gland 
disease or other illnesses, and another being failure to 
blind the investigator that performed CT image analysis 
to the treatment of dogs. Additionally, the experimen-
tal CT model consisting of repetitive scanning of the 
whole adrenal gland every 15 seconds (as in the first 
1.5 minutes for each dog in this study) is not clinically 
feasible but was done in an effort to generate informa-
tion about the volume of the adrenal glands. Nonethe-
less, our results provide useful information about the 
pharmacokinetics of contrast medium in the adrenal 
glands of healthy dogs.
Our findings supported that the dose of contrast 
medium and the timing of postinjection CT scanning 
are the main determinants of peak attenuation for ad-
renal glands in healthy dogs, whereas the effects on 
attenuation of the 3 contrast medium injection proto-
cols tested were of minor importance. The exponen-
tially decelerated injection method was complex and 
not user-friendly, required considerable calculation, 
and seemed therefore prone to error. A constant rate 
injection protocol delivering a total dose of 700 mg 
of iodine/kg over 20 seconds and scans obtained ap-
proximately 30 seconds after the start of contrast in-
jection provided images with maximum adrenal gland 
attenuation values in healthy dogs.
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